Diabetes and Schizophrenia

Current Diabetes Reports
Jaana SuvisaariOuti Mantere

Abstract

People with schizophrenia have 2- to 5-fold higher risk of type 2 diabetes than the general population. The traditional risk factors for type 2 diabetes, especially obesity, poor diet, and sedentary lifestyle, are common in people with schizophrenia already early in the course of illness. People with schizophrenia also often have low socioeconomic status and income, which affects their possibilities to make healthy lifestyle choices. Antipsychotic medications increase the risk of type 2 diabetes both directly by affecting insulin sensitivity and indirectly by causing weight gain. Lifestyle modification interventions for prevention of diabetes should be an integral part of treatment of patients with schizophrenia. In the treatment of type 2 diabetes in patients with schizophrenia, communication and collaboration between medical care and psychiatric treatment providers are essential.

References

Feb 4, 2003·The American Journal of Psychiatry·Martina C M RyanJogin H Thakore
Mar 9, 2004·The Journal of Clinical Psychiatry·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Oct 7, 2005·The Journal of Nervous and Mental Disease·Gail L DaumitLisa B Dixon
Jan 3, 2007·Archives of General Psychiatry·Jonna PeräläJouko Lönnqvist
Aug 8, 2007·Archives of General Psychiatry·Hannu JuvonenJouko Lönnqvist
Nov 9, 2007·European Archives of Psychiatry and Clinical Neuroscience·Jaana SuvisaariAntti Reunanen
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Ren-Rong WuLe-Hua Li
Aug 21, 2008·Psychological Medicine·S E SaarniJ Lönnqvist
Sep 23, 2008·Schizophrenia Research·Jonna PeräläJaana Suvisaari
Jul 1, 2010·Expert Review of Neurotherapeutics·Lawrence Maayan, Christoph U Correll
Oct 1, 2010·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A VerrottiF Chiarelli
Nov 9, 2010·Psychiatry Research·Ainara ArnaizMaria A Pérez-Ansorena
Feb 9, 2011·Archives of General Psychiatry·Debra L Foley, Katherine I Morley
Mar 19, 2011·Biological Psychiatry·Thomas HansenThomas Werge
Aug 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·M De HertA J Mitchell
Dec 24, 2011·The American Journal of Psychiatry·Michael E BenrosPreben B Mortensen
Jun 2, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter ManuMarc De Hert
Jun 22, 2012·BMC Psychiatry·Mario FioravantiMaria Elena Cinti
Jul 5, 2012·The Australian and New Zealand Journal of Psychiatry·Cherrie A GalletlyVera A Morgan
Sep 26, 2012·Social Psychiatry and Psychiatric Epidemiology·Jaana T SuokasJari Tiihonen
Nov 17, 2012·Journal of Psychiatric Research·Salvatore DipasqualeValeria Mondelli
Dec 22, 2012·Psychosomatic Medicine·Jaana SuvisaariTommi Härkänen
Jan 3, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Faith DickersonRobert H Yolken
Jan 25, 2013·Psychopharmacology·Melanie D GuenetteGary J Remington
Mar 23, 2013·The New England Journal of Medicine·Gail L DaumitLawrence J Appel
Aug 13, 2013·Nature Genetics·UNKNOWN Cross-Disorder Group of the Psychiatric Genomics ConsortiumUNKNOWN International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)
Sep 10, 2013·Endocrinology and Metabolism Clinics of North America·Chao Deng
Feb 4, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·T RütherH J Möller
May 9, 2014·JAMA Psychiatry·Carsten Bøcker PedersenWilliam W Eaton
Aug 26, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·René Ernst NielsenChristoph U Correll
Sep 5, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·G A Rutter

❮ Previous
Next ❯

Citations

Aug 27, 2016·Nordic Journal of Psychiatry·Tomi VirtanenJaana Suvisaari
Aug 31, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Gilad GalItzhak Levav
Dec 7, 2017·Journal of Women's Health·Lucy Church BarkerSimone N Vigod
Oct 29, 2017·Nutritional Neuroscience·Özge KüçükerdönmezBurak Yıldız
Sep 8, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·Chun-Jen HuangChing-Hua Lin
Mar 17, 2018·Hormone Molecular Biology and Clinical Investigation·Kai G KahlUlrich Schweiger
Mar 30, 2017·Surgical Infections·Catherine M DickinsonAndrew H Stephen
Nov 25, 2018·Translational Psychiatry·Sophie HackingerEleftheria Zeggini
Nov 30, 2018·Frontiers in Psychiatry·Jaana SuvisaariTuukka T Raij
Nov 20, 2020·Brain Circulation·Leandro Bueno Bergantin
Apr 8, 2021·Nordic Journal of Psychiatry·Massar OmarRené Ernst Nielsen
Apr 17, 2021·European Archives of Psychiatry and Clinical Neuroscience·Chun-Jen HuangShih-Feng Weng
Dec 24, 2020·Nutrients·Nicolette StogiosMargaret K Hahn
Aug 31, 2021·Acta Psychiatrica Scandinavica·Emily SmithSri Mahavir Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Related Papers

Arquivos brasileiros de endocrinologia e metabologia
Cecília AttuxRodrigo A Bressan
The Mount Sinai Journal of Medicine, New York
Amulya T SiramMaria Skamagas
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
Marc DE HertRuud VAN Winkel
The New England Journal of Medicine
Jaakko TuomilehtoFinnish Diabetes Prevention Study Group
© 2021 Meta ULC. All rights reserved